Details of Company Address
Released
Released
Announcement PDF
ASX Announcement
19/05/2021
Change of registered address
Emyria Limited (ASX: EMD) (Emyria or the Company), advises that its registered address has
changed to:
D2, 661 Newcastle Street
Leederville
Western Australia 6007
The Company’s postal address, contact phone number and email address are unchanged.
This announcement has been approved and authorised for release by Simon
Robertson, Company Secretary of Emyria Limited.
For further information:
Dr Michael Winlo
Managing Director
(08) 6559 2800
mwinlo@emyria.com
Lexi O’Halloran
Media/Investor Relations
+ 61 (0) 404 577 076
lexi@janemorganmanagement.com.au
About Emyria (www.emyria.com)
Emyria Limited is a data-backed, drug development company. Emyria’s Treatments target
unmet needs and are focused on obtaining approval from major global regulators. Emyria’s
drug development programs are informed by insights generated from extensive analysis of
Emyria Data - deep, ethically-sourced clinical evidence that is gathered with patients across
Emyria’s independent clinical services (Emerald Clinics - www.emeraldclinics.com.au)
Emyria Data provides deep treatment insights and is therefore a source of unique IP,
strategically designed drug development and personalised care programs.
Share your feedback
Discover